Nurse in Cancer Hoax Gets 2 Years in Prison for Theft Nurse in Cancer Hoax Gets 2 Years in Prison for Theft
A former Ohio State University nurse anesthetist told coworkers and her employer that she had metastatic lung cancer and bilked thousands of dollars from them.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Licorice contains powerful cancer-killing properties
(Natural News) When you ask people if they like licorice, you’re likely to get a spirited response. Some people can’t get enough of its unique flavor, while others can’t stand the sight of it. It turns out that it’s not just its taste that inspires a gamut of reactions; its use in fighting breast cancer... (Source: NaturalNews.com)
Source: NaturalNews.com - November 28, 2018 Category: Consumer Health News Source Type: news

High doses of vitamin C can reduce inflammation in cancer patients
(Natural News) Vitamin C is so much more than just a potent immune booster to help ward off wintertime colds and flus. It is also one of the best weapons we have against disease-causing inflammation. Infection, autoimmune issues and the effects of the chemical environment we live in can all result in chronic inflammation. When... (Source: NaturalNews.com)
Source: NaturalNews.com - November 28, 2018 Category: Consumer Health News Source Type: news

Dandelion root detoxifies your liver and fights cancer
(Natural News) The liver is the single biggest organ in the body and is responsible for over 500 vitally important functions. Officially part of the digestive system, this amazing organ synthesizes protein, produces chemicals to help digest food and, perhaps most importantly, is an essential part of the body’s detoxification process. Although the liver is... (Source: NaturalNews.com)
Source: NaturalNews.com - November 28, 2018 Category: Consumer Health News Source Type: news

Online Cancer Information Is Often Unreliable
The greater the number of views and “ likes ” a YouTube video on prostate cancer received, the poorer the quality of the information provided tended to be. (Source: NYT Health)
Source: NYT Health - November 28, 2018 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Prostate Gland Prostate Cancer Science and Technology Medicine and Health Source Type: news

Experts: Magic Mouthwash Should'Vanish Into Thin Air'Experts: Magic Mouthwash Should'Vanish Into Thin Air '
Mixed-medication mouth rinses are commonly used for oral pain and inflammation that accompany some cancer treatments. Should they be?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: New strategy defeats cancer cells that evade chemotherapy
Scientists have found that making the cancer cells that survive chemotherapy more aggressive results in them being vulnerable to anti-inflammatories. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 28, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Novel Blood Test a Potential'Game Changer' in Ovarian Cancer Novel Blood Test a Potential'Game Changer' in Ovarian Cancer
Novel blood test picks up ovarian cancer at all stages of disease, including early stage, opening the door to much earlier detection and optimally increasing survival odds.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Paradox: Obesity Promotes Tumors but Boosts Immunotherapy Paradox: Obesity Promotes Tumors but Boosts Immunotherapy
Obesity increases the risk for cancer, but, somewhat paradoxically, cancer patients who are obese and who undergo immunotherapy have better responses.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

How Microsoft Aims to Help'Solve the Problem' of Cancer How Microsoft Aims to Help'Solve the Problem' of Cancer
Software giant Microsoft has entered the healthcare arena, and improving cancer care and diagnostics is high on its list.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Morning Break: Walter Reed Shooter Scare; Generic EpiPen Still $300; Money-Back Cancer Drug
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 28, 2018 Category: Primary Care Source Type: news

Nurse wins award for ‘outstanding’ prostate cancer care
A nurse from Wrexham has won a charity award for her “outstanding” commitment to prostate cancer patients. (Source: Nursing Times)
Source: Nursing Times - November 28, 2018 Category: Nursing Source Type: news

Medical News Today: End-of-life symptoms of metastatic breast cancer
The end-of-life symptoms associated with metastatic breast cancer depend on where a person ’s cancer has spread to, and they can include both physical and mental issues. Treatment focuses on improving quality of life and caring for the individual’s physical, emotional, and spiritual needs. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 28, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron(TM) from GE Healthcare
Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in Which Metastron™ is Already Registered and Approved for Sale NEW YORK, November 28, 2018 -- (Healthcare Sales & Marketing Network) -- ... Biopharmaceuticals, Oncology, Acquisitions Q BioMed, GE Healthcare, Metastron (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 28, 2018 Category: Pharmaceuticals Source Type: news

MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement
SAN DIEGO, Nov. 28, 2018 -- (Healthcare Sales & Marketing Network) -- MabVax Therapeutics Holdings, Inc. (OTC Pink: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the t... Biopharmaceuticals, Oncology, Venture Capital MabVax Therapeutics, monoclonal antibody, pancreatic cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 28, 2018 Category: Pharmaceuticals Source Type: news

RSNA: Mammography May Benefit 30-Year-Olds With Risk Factors
WEDNESDAY, Nov. 28, 2018 -- Women with one of three breast cancer risk factors may benefit from mammography screening beginning at age 30, according to a study presented at the annual meeting of the Radiological Society of North America, held from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2018 Category: Pharmaceuticals Source Type: news

Lung cancer symptoms: This feeling in your chest could be tell-tale sign of the disease
LUNG cancer symptoms can be difficult to detect in the early stages as they usually don ’t become apparent until the tumour has grown. But one sign to be wary of is if your chest feeling a particular way. (Source: Daily Express - Health)
Source: Daily Express - Health - November 28, 2018 Category: Consumer Health News Source Type: news

For Some Women, Mammograms May Need to Begin at 30: Study
WEDNESDAY, Nov. 28, 2018 -- Women at increased risk for breast cancer should start receiving mammograms earlier than recommended, even as young as age 30, a new study contends. Young women who have dense breasts or a family history of breast cancer... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 28, 2018 Category: General Medicine Source Type: news

Injury threshold of oral contact with hot foods and method for its sensory evaluation - Lachenmeier DW, Lachenmeier W.
Epidemiological studies indicate an increased risk of esophageal cancer from the consumption of very hot foods and beverages. The contact time and the contact temperature are decisive for the risk of injury. However, measuring the contact temperature is no... (Source: SafetyLit)
Source: SafetyLit - November 28, 2018 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

How Microsoft Aims to Help Solve Problem of Cancer
How Microsoft Aims to Help 'Solve the Problem' of Cancer (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 28, 2018 Category: General Medicine Source Type: news

For Some Women, Mammograms May Need to Begin at 30: Study
Title: For Some Women, Mammograms May Need to Begin at 30: StudyCategory: Health NewsCreated: 11/28/2018 12:00:00 AMLast Editorial Review: 11/28/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 28, 2018 Category: Cancer & Oncology Source Type: news

Vitrakvi Approved for Cancers With Certain Genetic Trait
Title: Vitrakvi Approved for Cancers With Certain Genetic TraitCategory: Health NewsCreated: 11/27/2018 12:00:00 AMLast Editorial Review: 11/28/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 28, 2018 Category: Cancer & Oncology Source Type: news

Kenya: Cancer of the Oesophagus is Kenya's Deadliest
[Nation] Oesophagus cancer is now the leading killer in Kenya, overtaking cervix, breast, stomach and prostate cancers, according to recent data from World Health Organisation. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 28, 2018 Category: African Health Source Type: news

Vapers can avoid relapsing to smoking, even after the odd cigarette
(University of East Anglia) New research finds vapers can avoid relapsing back into smoking, even after the odd cigarette.While vapers may occasionally have the odd smoking lapse, they don't see it as 'game over' for their quit attempt and it doesn't have to lead to a full relapse.The findings suggest that vaping encourages not just smoking cessation, but long-term relapse prevention. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

Altering cancer metabolism helps treatments attack tumors
(Cancer Research UK) Restricting the ability of cancer cells to metabolize sugar could make oncolytic viruses more effective at attacking them, suggests a study published today in the journal Cancer Research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

Virtual library of 1 million new macrolide scaffolds could help speed drug discovery
(North Carolina State University) Researchers from North Carolina State University have created the largest publicly available virtual library of macrolide scaffolds. The library -- called V1M -- contains chemical structures and computed properties for 1 million macrolide scaffolds with potential for use as antibiotics or cancer drugs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 28, 2018 Category: International Medicine & Public Health Source Type: news

Defective protein factories in disease
(KU Leuven) Ever since the 1960s, the medical world has wondered why some patients who suffer from illnesses resulting from inadequate cell division are much more susceptible to cancer which is conversely characterized by excessive cell division. The Laboratory for Disease Mechanisms in Cancer in Leuven, Belgium has now succeeded in unraveling the mechanism of how defective ribosomes can cause both insufficient and excessive cell division. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

A terrible choice: Cancer treatment or hospice care, but not both
(University of Colorado Anschutz Medical Campus) Colorado studies explore costs, benefits, and experiences of veterans receiving concurrent cancer treatment and hospice care; their findings may provide the basis for wider adoption of this nonstandard practice. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

91 percent response rate for venetoclax against newly diagnosed AML in older adults
(University of Colorado Anschutz Medical Campus) Clinical trial results published in the journal Nature Medicine and being presented this weekend at the American Society for Hematology Annual Meeting show 91 percent response rate to the combination of venetoclax with azacitidine in older adults newly diagnosed with acute myeloid leukemia (AML). Of 33 patients given combination venetoclax and azacitidine, 20 experienced a complete response (aka complete remission) and eight experienced a complete response but with continued low blood counts. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

FDA approves new targeted drug for leukemia tested at University of Pennsylvania
(University of Pennsylvania School of Medicine) The US Food and Drug Administration (FDA) has approved the first ever inhibitor drug specifically approved for treating patients with relapsed or refractory acute myeloid leukemia (AML) with a mutation in the Fms-like tyrosine kinase 3 (FLT3) gene. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

Checkmating tumors
(Max Delbr ü ck Center for Molecular Medicine in the Helmholtz Association) Chess and cancer research have one thing in common: one must act strategically to defeat the opponent. And that's exactly what scientists at the MDC are doing. They are seeking to selectively make only those cancer cells aggressive that would otherwise evade chemotherapy -- and then lure them into a trap. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

New stem-cell therapy to improve fight against leukemia
(University of Zurich) Stem-cell transplantation is an effective form of therapy to fight leukemia. In many cases, however, the transferred immune cells of the donor also attack the recipients' healthy tissue - often with fatal consequences. Researchers at the University of Zurich have now identified a molecule that plays a key role in this process. Blocking this molecule could significantly improve the outcome of patients receiving stem-cell transplants. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

Single cell sequencing sheds light on why cancers form in specific cell types
(University of Illinois at Chicago) Researchers build, then use single cell sequencer to identify and characterize a subpopulation of cells in the eye where cancer originates. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 28, 2018 Category: Biology Source Type: news

Skin cancer rates far higher than previously thought, according to new national database
(Queen Mary University of London) Data from a newly established UK skin cancer database, the largest of its kind in the world, has revealed that there are over 45,000 cutaneous squamous cell carcinomas every year in England, 350 percent more than previous estimates suggested. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 28, 2018 Category: International Medicine & Public Health Source Type: news

How much do you trust Dr. Google?
(University of Surrey) Women experiencing signs of breast cancer vary in how they value, use, and trust 'Dr. Google' when making sense of their symptoms, a new study in the journal Health, Risk& Society reports. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 28, 2018 Category: International Medicine & Public Health Source Type: news

New York Genome Center receives NYS approval for whole genome sequencing cancer test
(New York Genome Center) The New York Genome Center (NYGC) has received approval from the New York State Department of Health to offer whole genome and RNA transcriptome sequencing in its Clinical Laboratory Evaluation Program (CLEP)-certified laboratory. This is the first approval by New York State for a whole genome sequencing test for oncology, and currently NYGC's Clinical Lab is the only one to offer it. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 28, 2018 Category: International Medicine & Public Health Source Type: news

The future of fighting cancer: Zapping tumors in less than a second
(DOE/SLAC National Accelerator Laboratory) New accelerator-based technology being developed by the Department of Energy's SLAC National Accelerator Laboratory and Stanford University aims to reduce the side effects of cancer radiation therapy by shrinking its duration from minutes to under a second. Built into future compact medical devices, technology developed for high-energy physics could also help make radiation therapy more accessible around the world. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 28, 2018 Category: International Medicine & Public Health Source Type: news

Nanoscale blood test technique set to springboard cancer discoveries
(Cancer Research UK) A technique to get more information from the blood of cancer patients than previously possible has been developed. The discovery could potentially accelerate early diagnosis, speed up drug discovery and lead to advancements in personalized medicines. The Cancer Research UK-funded study is published in Advanced Materials today. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

Cryoablation shows promise in treating low-risk breast cancers
(Radiological Society of North America) Cryoablation -- the destruction of cancer cells through freezing -- shows early indications of effectiveness in treating women with low-risk breast cancers, according to new. Researchers said that over the four years of the study, there has only been one case of cancer recurrence out of 180 patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

New study supports mammography screening at 30 for some women
(Radiological Society of North America) A new, large-scale study of more than 5 million mammograms found that annual mammography screening beginning at age 30 may benefit women with at least one of three specific risk factors: dense breasts, a personal history of breast cancer or a family history of breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

Genetic mutation drives tumor regression in Tasmanian Devils
(Washington State University) Washington State University scientists have discovered genes and other genetic variations that appear to be involved in cancerous tumors shrinking in Tasmanian devils. Their research could have important implications for treating cancer in humans and other mammals. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 28, 2018 Category: Infectious Diseases Source Type: news

Are Patients Willing to Travel for Cancer Surgery?
Survey results published inJAMA Network Openlooked at motivating factors behind patient travel and how far they were willing to go for treatment. (Source: CancerNetwork)
Source: CancerNetwork - November 28, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Cancer survivor dances with Nutcracker Royal Ballet stars
Charlie, 11, became an aspiring ballerina when she took it up to build up her strength after chemotherapy. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 28, 2018 Category: Consumer Health News Source Type: news

For Some Women, Mammograms May Need to Begin at 30: Study
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

For Some Women, Mammograms May Need to Begin at 30: Study
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

Bristol-Myers Squibb Says Cancer Drug Combination Fails Late-Stage Trial Bristol-Myers Squibb Says Cancer Drug Combination Fails Late-Stage Trial
Bristol-Myers Squibb Co said on Monday a combination of two of its cancer drugs, being tested as a maintenance therapy, did not meet the main goal of extending the lives of lung cancer patients in a late-stage trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 27, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

What's Hot at SABCS 2018 What's Hot at SABCS 2018
At the world ’ s largest breast cancer meeting, studies on treatment duration, optimal sequencing, and novel neoadjuvant strategies are all on the agenda.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 27, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Teva to recall certain blood pressure medicine in U.S
Teva Pharmaceutical Industries Ltd is recalling certain combinations of blood pressure drug valsartan in the United States following the detection of a probable cancer-causing impurity, the latest global recall of the medicine. (Source: Reuters: Health)
Source: Reuters: Health - November 27, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Record FIVE MILLION British women are overdue for life-saving smear tests
Cervical cancer screening in Britain has fallen to an all-time low, with nearly five million women overdue for testing. (Source: the Mail online | Health)
Source: the Mail online | Health - November 27, 2018 Category: Consumer Health News Source Type: news

One in Five Cancer Tumors Grow Before Shrinking: Nivolumab One in Five Cancer Tumors Grow Before Shrinking: Nivolumab
Immunotherapy can cause tumors to grow before they decrease in size, so patience is needed for the treatment to work, new research shows.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 27, 2018 Category: Radiology Tags: Radiology News Source Type: news